Magnetic Resonance Elastography to Monitor Response to Manual Therapy in Myofascial Pain
2 other identifiers
interventional
78
1 country
2
Brief Summary
The purpose of this research is to develop and test new Magnetic Resonance Imaging (MRI) methods that look at how muscles and tissues under the skin (myofascial tissues) move and respond to pressure. The investigators want to see how these tissues differ between healthy people and people with pain or injury, and how they change after hands-on treatment (Tuina therapy). The results will also be compared to a group that receives standard care without Tuina therapy. The main questions this study aims to answer are:
- 1.Can MR elastography (MRE) show changes in how the fascia and the layers between muscles move and stretch before and after manual therapy?
- 2.Do changes seen on MRE scans match changes in pain, function, and other symptoms reported by participants?
- 3.Can MRE measurements before treatment help predict which participants are most likely to improve with manual therapy?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2026
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2025
CompletedFirst Posted
Study publicly available on registry
December 12, 2025
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 30, 2027
February 3, 2026
February 1, 2026
1.6 years
December 4, 2025
February 2, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Pain, Enjoyment, and General Activity (PEG) score
The Pain, Enjoyment, and General Activity (PEG) score is a three-item questionnaire asking individuals to rate their Pain, Enjoyment of life, and General activity on a scale of 0 to 10 over the past week. The PEG score is the average of the three responses, ranging from 0 to 10, with higher scores indicating more severe pain or interference with life
Baseline, 1 day post-intervention, 3 weeks post-intervention
Study Arms (2)
Tuina + Usual Care
EXPERIMENTALParticipants will receive Tuina therapy twice weekly for three consecutive weeks (a total of six sessions) in addition to usual care.
Usual Care Only
ACTIVE COMPARATORParticipants will receive usual care only for three weeks, no additional manual therapy will be provided.
Interventions
Tuina is a manual therapy involving techniques that apply targeted shear and stretching forces along muscular and fascial planes. Tuina therapy will be administered to subjects twice weekly for three consecutive weeks (a total of six sessions). Each session will last 30-60 minutes and will be administered by licensed Tuina practitioners trained and credentialed at Mayo Clinic.
Standard care will be followed, including a patient education course, lifestyle guidance, cognitive-behavioral therapy, and home remedies.
Eligibility Criteria
You may qualify if:
- Adult males or females (age ≥ 18 years)
- A history of chronic low back for at least 3 months. (Measured by patient history and physical exam)
- A palpable taut band or nodule within the skeletal muscle
- Hypersensitive tender spot within the taut band
- Recognition of current pain complaint by pressure on the tender nodule/taut band
- Painful limit to the full stretch range of motion
You may not qualify if:
- Pregnancy or breastfeeding
- Any contraindication to an MRI exam, or severe claustrophobia that would prevent safe completion of the scan
- Previous therapy in the area to be treated within 3 months
- Previous severe back injury (including fracture) or surgery
- Any neurological conditions or active systemic disease (e.g. diabetes, peripheral vascular disease, cancer, rheumatoid arthritis) that impaired sensation/pain perception
- Severe osteoarthritis
- Skin injuries in the area to be treated
- Inability to provide consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Ziying Yin, Ph.D.
Mayo Clinic
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 4, 2025
First Posted
December 12, 2025
Study Start
February 1, 2026
Primary Completion (Estimated)
August 30, 2027
Study Completion (Estimated)
August 30, 2027
Last Updated
February 3, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share